IDEXX LABORATORIES INC /DE Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Idexx Laboratories Inc /De quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2017 to Q3 2024.
  • Idexx Laboratories Inc /De Deferred Income Tax Liabilities, Net for the quarter ending September 30, 2024 was $5.66M, a 46.6% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.66M -$4.94M -46.6% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $10M +$4.46M +80% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $8.75M +$2.92M +50.1% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $7.24M -$915K -11.2% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $10.6M -$3.89M -26.9% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $5.57M -$5.28M -48.7% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $5.83M -$1.64M -21.9% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $8.15M -$785K -8.79% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $14.5M -$820K -5.36% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $10.9M -$4.62M -29.8% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $7.46M -$11.1M -59.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $8.94M -$2.77M -23.7% Dec 31, 2021 10-K 2023-02-16
Q3 2021 $15.3M -$12.3M -44.5% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $15.5M -$21.1M -57.7% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $18.6M -$20.3M -52.3% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $11.7M -$21.3M -64.6% Dec 31, 2020 10-K 2022-02-16
Q3 2020 $27.6M -$6.14M -18.2% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $36.6M +$4.18M +12.9% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $38.9M +$5.98M +18.2% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $33M +$3.76M +12.8% Dec 31, 2019 10-K 2021-02-12
Q3 2019 $33.7M -$6.17M -15.5% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $32.4M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $32.9M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $29.3M +$3.91M +15.4% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $39.9M Sep 30, 2018 10-Q 2018-11-01
Q4 2017 $25.4M Dec 31, 2017 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.